<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1095</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15107837</PubmedId>
            <Abstract>Tenofovir, also known as PMPA, R-9-(2-(phosphonomethoxypropyl)adenine, is a nucleotide reverse transcriptase (RT) inhibitor. We have determined the crystal structures of two related complexes of HIV-1 RT with template primer and tenofovir: (i) a ternary complex at a resolution of 3.0 A of RT crosslinked to a dideoxy-terminated DNA with tenofovir-diphosphate bound as the incoming substrate; and (ii) a RT-DNA complex at a resolution of 3.1 A with tenofovir at the 3' primer terminus. The tenofovir nucleotide in the tenofovir-terminated structure seems to adopt multiple conformations. Some nucleoside reverse transcriptase inhibitors, including 3TC and AZT, have elements ('handles') that project beyond the corresponding elements on normal dNTPs (the 'substrate envelope'). HIV-1 RT resistance mechanisms to AZT and 3TC take advantage of these handles; tenofovir's structure lacks handles that could protrude through the substrate envelope to cause resistance.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>469-74</ArticlePages>
            <ArticleTitle>Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Tuske</LastName>
                    <ForeName>Steve</ForeName>
                </Author>
                <Author>
                    <LastName>Sarafianos</LastName>
                    <ForeName>Stefan G</ForeName>
                </Author>
                <Author>
                    <LastName>Clark</LastName>
                    <ForeName>Arthur D</ForeName>
                    <Suffix>Jr</Suffix>
                </Author>
                <Author>
                    <LastName>Ding</LastName>
                    <ForeName>Jianping</ForeName>
                </Author>
                <Author>
                    <LastName>Naeger</LastName>
                    <ForeName>Lisa K</ForeName>
                </Author>
                <Author>
                    <LastName>White</LastName>
                    <ForeName>Kirsten L</ForeName>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Michael D</ForeName>
                </Author>
                <Author>
                    <LastName>Gibbs</LastName>
                    <ForeName>Craig S</ForeName>
                </Author>
                <Author>
                    <LastName>Boyer</LastName>
                    <ForeName>Paul L</ForeName>
                </Author>
                <Author>
                    <LastName>Clark</LastName>
                    <ForeName>Patrick</ForeName>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Gang</ForeName>
                </Author>
                <Author>
                    <LastName>Gaffney</LastName>
                    <ForeName>Barbara L</ForeName>
                </Author>
                <Author>
                    <LastName>Jones</LastName>
                    <ForeName>Roger A</ForeName>
                </Author>
                <Author>
                    <LastName>Jerina</LastName>
                    <ForeName>Donald M</ForeName>
                </Author>
                <Author>
                    <LastName>Hughes</LastName>
                    <ForeName>Stephen H</ForeName>
                </Author>
                <Author>
                    <LastName>Arnold</LastName>
                    <ForeName>Eddy</ForeName>
                </Author>
            </Authors>
            <Affiliations>Center for Advanced Biotechnology and Medicine and Rutgers University Department of Chemistry and Chemical Biology, 679 Hoes Lane, Piscataway, New Jersey 08854-5638, USA.</Affiliations>
            <ArticleChemicalList>DNA Primers;DNA, Viral;Organophosphonates;Organophosphorus Compounds;Reverse Transcriptase Inhibitors;Tenofovir;HIV Reverse Transcriptase;Adenine</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adenine(analogs &amp; derivatives; chemistry); Base Sequence; DNA Primers; DNA, Viral(chemistry); HIV Reverse Transcriptase(chemistry); Models, Molecular; Organophosphonates; Organophosphorus Compounds(chemistry); Reverse Transcriptase Inhibitors(chemistry); Tenofovir</ArticleMeshHeadingsList>
            <Journal>
                <Volume>11</Volume>
                <Issue>5</Issue>
                <Title>Nature structural &amp; molecular biology</Title>
                <Issn>1545-9993</Issn>
                <MedlineTa>Nat Struct Mol Biol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Epitope of Fab28 on HIV-1 RT</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>R199, Q222, K223, E224, P225, P226, F227, W229, M230, R358</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>NP_789739.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11676</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>PDB 1T03</LocationOfData>
                <EpitopeId>150096</EpitopeId>
                <ReferenceRegion>R199, Q222, K223, E224, P225, P226, F227, W229, M230, R358</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope residues are calculated from the PDB structure [PDB: 1T03] as the antigen residues at 4 Ã… distance from the antibody.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1 and PDB 1T03</LocationOfData>
                        <BCellId>1838737</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Age>8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>NP_789739.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HIV-1 RT (66 kDa form)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>2 doses at a 2-wk interval and 1 dose 4 days before cell fusion</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Ferris et al. (1990) Virology 175(2): 456-464 [PMID: 1691562]. Mice were immunized with purified RT (66 kDa form).</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>3.1</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of Fab28 on the HIV-1 RT p51 subunit was determined from the crystal structure of Fab28 bound to the complex of HIV-1 RT p51/p66 dimer cross-linked to tenofovir terminated template primer DNA (27-mer/21-mer). Fab28 binds to the p51 palm subdomain and has no contacts with either the p66 subunit or the DNA. The HIV-1 RT p51 subunit contained the C280S mutation.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>28</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>Fab28</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1T03_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1T03_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>HIV-1 RT p51/p66 dimer</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>NP_789739.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>11676</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>YP_001856242.1</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>11676</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1T03</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>B</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <CuratedContacts>
                                <EpitopeResidues>B: ;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>B: R199, Q222, K223, E224, P225, P226, F227, W229, M230, R358</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: S32, W54, W55, D56, D58, R60, I102, T103, S104, V105, T106, S108; L: Y32, Y50, Y91, S92, K93, F94</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>736.1</ContactAreaForAntigen>
                                <ContactAreaForAntibody>648.2</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

